Focal Myelomalacia: Causes and Treatment Options

Focal myelomalacia is localized softening and death of spinal cord tissue, typically caused by an interruption of blood supply or direct physical damage to a specific segment of the cord. Unlike diffuse spinal cord injuries that affect long stretches of tissue, the damage here is concentrated in a relatively small area, though the neurological consequences can still be severe depending on location and depth. The causes range from traumatic disc herniations and spinal cord infarctions to radiation injury, and treatment depends heavily on what triggered the tissue loss, how quickly it is identified, and whether the surrounding cord is still under threat.

How Spinal Cord Tissue Breaks Down

The spinal cord has very little ability to regenerate once its neurons and supporting cells die. When a segment of the cord loses its blood supply or is crushed by displaced bone or disc material, the affected tissue goes through a characteristic sequence: the cells swell, inflammatory cells move in, and the normal architecture is gradually replaced by a soft, disorganized mass of debris. In studies of dogs with disc-related spinal cord injury, the damaged cord center showed edema, axonal swelling, neuronal death, and infiltration by immune cells. In the most severe cases, normal spinal cord tissue was entirely replaced by an amorphous mixture of cellular debris, immune cells, and blood.¹ That end-stage picture is myelomalacia: the cord at that level is functionally gone.

What makes focal myelomalacia distinct from a broader spinal cord injury is that the damage stays contained. The tissue softening does not keep spreading up and down the cord. When it does spread, the condition is called progressive myelomalacia, which is a much more dangerous and often fatal process. In focal cases, the remaining healthy cord above and below the lesion can still function, so the neurological deficits tend to reflect only the segment that was destroyed.

Trauma and Disc Herniation

The most common pathway to focal myelomalacia is mechanical injury to the spinal cord. In humans, this typically means a vertebral fracture, dislocation, or severe disc herniation that crushes or compresses a segment of the cord. In dogs and cats, acute intervertebral disc extrusion is the leading cause. The disc material erupts into the spinal canal at high speed and impacts the cord, causing a combination of direct mechanical damage and disrupted blood flow to the affected segment.

The severity matters enormously. A mild compression may cause temporary dysfunction that resolves once the pressure is removed. But when the compression is severe enough to cut off blood supply to the center of the cord, infarction occurs and the tissue dies. In veterinary medicine, progressive myelomalacia, the spreading form, develops in roughly 11 to 17.5 percent of dogs that present with complete loss of motor function and pain sensation in their hind limbs after a disc extrusion.² Focal myelomalacia in the same context tends to appear in less devastating injuries, where the damage is bad enough to kill a patch of cord but not bad enough to set off a chain reaction.

Vascular Causes

The spinal cord depends on a delicate network of arteries. When one of those vessels is blocked, the tissue it supplies can infarct, just like a stroke in the brain. Spinal cord infarctions are most often tied to problems in the aorta, including surgical complications and aortic disease, but a less recognized cause is fibrocartilaginous embolism. This occurs when material from the soft center of an intervertebral disc somehow enters the spinal blood vessels and lodges there, cutting off flow. The mechanism is thought to involve retrograde movement of disc material from structures called Schmorl’s nodes into the spinal vasculature after a disc herniates.³

Fibrocartilaginous embolism accounts for a small share of spinal cord infarctions, around 5.5 percent in one review, but it is probably underdiagnosed because it mimics other conditions like transverse myelitis.⁴ Patients often present with sudden-onset weakness or paralysis after a minor physical exertion, which can look like many other spinal emergencies. The resulting myelomalacia is typically focal, affecting just the territory supplied by the blocked vessel. Because there is no ongoing compression, the treatment approach differs significantly from trauma-related cases.

Radiation-Induced Myelomalacia

Radiation therapy directed at the spine or nearby structures can damage the spinal cord, sometimes months or even years after treatment. This delayed radiation myelopathy results from the death of blood vessel lining cells inside the cord, which breaks down the barrier between the blood and spinal cord tissue. The cascade that follows leads to loss of the insulating myelin sheath around nerve fibers and eventually tissue death.⁵ In one reported case, a patient developed radiation myelopathy nine months after radiation beam therapy directed at the left thorax.⁶

Radiation myelopathy was becoming rare with modern dose-planning techniques, but it has re-emerged as spine-directed stereotactic body radiation therapy and re-irradiation become more common in cancer treatment.⁵ Because the damage is driven by vascular breakdown rather than direct compression, the resulting myelomalacia is focal and corresponds to the segment of cord that received the highest dose. There is currently no proven way to reverse it once it has set in, which makes careful radiation dose planning the primary line of defense.

How MRI Identifies Focal Myelomalacia

MRI is the tool that clinicians rely on to see myelomalacia and distinguish it from reversible swelling or simple compression. On standard MRI sequences, myelomalacia shows up as a bright signal on fluid-sensitive images, reflecting the fact that the dead tissue has been partly replaced by fluid-filled space. More advanced diffusion-weighted MRI techniques have improved the ability to detect subtle cord damage and distinguish it from surrounding normal tissue.⁷

Two specific MRI features carry strong prognostic weight. A bright signal on T2-weighted images suggests edema or tissue damage, and can sometimes be reversible. But when a dark signal also appears on T1-weighted images at the same level, it suggests more established tissue destruction, often with hemorrhage. In a study of cervical spondylotic myelopathy, patients with T1 dark signal had a 14-fold increased risk of being unable to walk independently compared to those without it. The length of the bright T2 signal also mattered: for every additional millimeter, the risk of dependent walking rose by about 35 percent.⁸ In traumatic myelopathy, patients with dark signal on initial MRI showed no significant clinical improvement, while those whose cords appeared normal on MRI all recovered.⁹

The practical takeaway is that MRI does not just confirm whether myelomalacia is present. The pattern and extent of the signal changes help predict how much recovery is realistic, which guides decisions about whether aggressive treatment is likely to help.

Acute Medical Management

When focal myelomalacia results from trauma, the first priority is protecting whatever healthy cord tissue remains. In acute traumatic spinal cord injury, the standard approach is to keep blood pressure elevated, typically pushing the mean arterial pressure above 85 mmHg for up to seven days, to maintain blood flow through the injured segment.¹⁰ The logic is straightforward: tissue at the edges of the injury zone may be starved of blood but not yet dead, and restoring flow quickly enough can prevent the area of myelomalacia from expanding.

One treatment that has fallen out of favor is high-dose methylprednisolone, a steroid that was once given routinely after spinal cord injuries. Current evidence does not support its use for improving outcomes, and it carries significant side effects including increased infection risk and gastrointestinal bleeding. Its use is now strongly discouraged.¹¹ Beyond blood pressure support, acute care focuses on preventing complications like blood clots, pressure sores, and respiratory problems while the full extent of the injury declares itself over the first days to weeks.

Surgical Approaches

Surgery for focal myelomalacia targets the cause of cord compression rather than the dead tissue itself. If a herniated disc, bone fragment, or tumor is pressing on the cord and threatening to extend the damage, removing that pressure is urgent. Standard decompressive procedures like laminectomy remove part of the vertebral bone to give the cord more room. However, in cases where the cord itself is severely swollen, simply removing bone may not be enough because the tough membrane around the cord, the dura, can continue to squeeze it. Expansion duroplasty addresses this by opening the dura and patching it with a larger piece of material, giving the swollen cord room to expand without further compression.¹²

In veterinary medicine, where progressive myelomalacia after disc extrusion is a well-recognized emergency, extensive hemilaminectomy with durotomy has shown promise. A study of 34 dogs with presumptive progressive myelomalacia found that this combined approach appeared effective at halting the spread of tissue death and preventing further decline.¹³ Although this is a veterinary finding, it has influenced thinking about whether early aggressive decompression in humans might similarly limit the zone of myelomalacia when the damage is threatening to spread.

A separate surgical scenario involves post-traumatic syringomyelia, where a fluid-filled cyst forms within the damaged cord months or years after the initial injury. When this cyst causes worsening symptoms like pain, spasticity, or motor deterioration, surgery may be warranted. In a series of patients treated surgically, more than half of those with worsening motor function or spasticity improved after the procedure. When the cord was also tethered by scar tissue, simply releasing the tether caused the cyst to collapse in the majority of patients.¹⁴

Experimental and Emerging Therapies

Because the spinal cord does not naturally regenerate dead tissue, there is intense interest in therapies that might coax it to repair itself or at least limit the secondary damage that follows the initial injury. Two areas generate the most discussion: stem cell therapy and hyperbaric oxygen.

Stem cell transplantation has been tested in dozens of clinical trials for spinal cord injury. A large meta-analysis pooling data from 62 trials found that about 49 percent of patients showed at least one grade of improvement on a standard impairment scale after stem cell treatment, along with improvements in bladder and bowel function in a substantial number of patients. However, 28 different types of adverse effects were also documented, and the overall quality of the evidence remains limited.¹⁵ The authors of that analysis described clinical translation as “still premature,” reflecting the fact that most trials were small, uncontrolled, and used varying cell types and delivery methods. These results are encouraging enough to keep the research going but not solid enough to recommend the therapy as standard practice.

Hyperbaric oxygen therapy, which delivers pure oxygen at higher-than-normal atmospheric pressure, has shown protective effects in animal models of spinal cord injury. The proposed mechanisms include reducing inflammation, limiting cell death, and promoting the growth of new blood vessels in the injured segment.¹⁶ Some clinical studies have shown benefit, but the optimal timing, duration, and number of treatment sessions remain unresolved, and no large randomized trial has confirmed long-term effectiveness in humans.¹⁷ For now, hyperbaric oxygen is considered an adjunctive experimental option rather than a proven treatment for myelomalacia.

What MRI Patterns Mean for Recovery

Predicting who will recover function after focal myelomalacia and who will not is one of the harder problems in spinal cord medicine. The MRI findings discussed earlier are the most useful prognostic tools available. A systematic review of cervical spondylotic myelopathy studies confirmed that multiple segments of bright T2 signal, dark T1 signal, and the combination of the two were negative predictors of surgical outcome, though the overall evidence was graded as low quality.¹⁸ In plain terms, the more extensive and established the cord damage looks on MRI, the less likely the patient is to make a meaningful recovery even with surgery.

This does not mean that all patients with myelomalacia on MRI are beyond help. Patients with edema alone, shown by bright T2 signal without dark T1 changes, may still improve substantially. And even when recovery of lost function is limited, surgery to relieve ongoing compression can prevent further deterioration, which is a meaningful goal on its own. The MRI patterns help set realistic expectations and guide conversations between clinicians and patients about what treatment can and cannot achieve.

Rehabilitation After Spinal Cord Damage

Once the acute phase has passed and the extent of permanent damage is clearer, rehabilitation becomes the primary focus. For patients with incomplete injuries, where some function is preserved below the level of damage, intensive physical therapy can lead to real functional gains. A case report of interdisciplinary rehabilitation for incomplete cervical cord injury described a program centered on transfer training, gradual tolerance to sitting upright, and structured sessions five days per week, each lasting about an hour.¹⁹ Simple things like sitting up without fainting, transferring from a wheelchair to a bed, and building enough endurance for daily tasks can take weeks of structured work.

Rehabilitation after focal myelomalacia has a particular advantage over rehabilitation after more widespread cord damage: because the lesion is confined to a specific segment, the cord above and below retains its connections. This means that muscles controlled by segments above and below the damage can often be strengthened and retrained to compensate, at least partially, for what was lost. The specific deficits depend entirely on where in the cord the myelomalacia sits. A lesion in the cervical cord may affect the arms and hands. One in the thoracic cord may affect trunk stability and the legs. A lumbar-level lesion may impair bladder and bowel function along with leg strength.

Progressive Myelomalacia in Dogs

Progressive myelomalacia, in which the tissue softening does not stay focal but spreads up and down the cord, is far better characterized in veterinary medicine than in human medicine. It occurs most often in dogs after acute intervertebral disc extrusion and carries a grim prognosis. Signs of spreading damage developed within 48 hours of presentation in about half of the affected dogs in one series, and most were euthanized within three days of the onset of progressive signs. Nonspecific systemic signs such as fever, changes in breathing, or cardiovascular instability were documented in the majority of cases.²

In cats with spinal cord injuries from external trauma, a similar pattern has been observed: those that had lost deep pain sensation showed a high incidence of myelomalacia discovered during surgery or at postmortem examination.²⁰ The veterinary literature is worth noting here because much of what we know about the early pathology of myelomalacia, including the cellular changes described at the top of this article, comes from animal studies where histological examination of the cord was possible. These findings have directly informed how human clinicians think about the timing of intervention and the window during which secondary damage might still be preventable.

The aggressive surgical approach that has shown some success in veterinary cases, combining extensive bone removal with opening of the dura, represents an attempt to halt spreading damage before it becomes irreversible.¹³ Whether a parallel strategy could work in human patients who show early signs of expanding myelomalacia is an open question, but the veterinary results have at least established that the trajectory is not always irreversible if intervention is fast enough.